COMMUNIQUÉS West-GlobeNewswire

Treace Medical Concepts Reports First Quarter 2024 Financial Results
07/05/2024
PONTE VEDRA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
ClearPoint Neuro Reports First Quarter 2024 Results
07/05/2024
First Quarter Revenue Growth +41%; Record Revenue Achieved SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling [...]
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
07/05/2024
Highlights: First quarter revenue of $202 million grew 12% year-over-year, driven by Prenatal ( 22% ), Pharmacogenomics ( 21% ), and Hereditary Cancer ( 16% ). First quarter average revenue per test improved by 2% over [...]
SIGA Reports Financial Results for Three Months Ended March 31, 2024
07/05/2024
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 Million Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: [...]
Goodness Growth Holdings Announces First Quarter 2024 Results
07/05/2024
– Q1 2024 revenue of $21.1 million excluding discontinued operations and NY increased 44.5% year-over-year – – Submitted a substantial legal filing on May 2nd in the ongoing litigation with Verano – – Company announces [...]
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2024
07/05/2024
DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
07/05/2024
Inspire Reports Year-over-Year Revenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ( [...]
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
07/05/2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
07/05/2024
Company Announcement COPENHAGEN, Denmark; May 7, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,959 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
07/05/2024
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in key roles including business [...]
WAKE RADIOLOGY SUPPORTS TRIANGLE RACE FOR THE CURE WITH THIRD LARGEST TEAM, $11,100 CONTRIBUTION
07/05/2024
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, the oldest and largest outpatient imaging provider in the Triangle, contributed $11,100 to breast cancer research as a [...]
Correction: NTG Nordic Transport Group publishes interim report for Q1 2024
07/05/2024
Company announcement no. 5 – 24 7 May 2024 NTG Nordic Transport Group publishes interim report for Q1 2024 The interim report for Q1 2024 is enclosed. In connection with publication of the results for Q1 2024, a [...]
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
07/05/2024
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT® Expansion in the oncology segment Development of Eurobio Scientific proprietary product portfolio Increase of [...]
EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®
07/05/2024
EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT® Expansion dans le segment de l'oncologie Développement du portefeuille de produits propriétaires d' [...]
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
07/05/2024
ANX007 demonstrated significant, broad-based protection from vision loss in foveal and non-foveal patients, and in low light settings ANX007 protected key retinal structures important for vision: significant reduction [...]
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
07/05/2024
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE FOR AMYOTROPHIC [...]
AB Science:
07/05/2024
COMMUNIQUE DE PRESSE UNE NOUVELLE PUBLICATION DANS LA REVUE MÉDICALE MUSCLE & NERVE VALIDE L’UTILISATION DU DECLIN DU SCORE ALSFRS-R (ΔFS) POUR LE DESIGN DES ETUDES CLINIQUES ET LE CHOIX DE TRAITEMENT DES PATIENTS [...]
Philips shareholders approve all proposals at the AGM 2024
07/05/2024
May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re- [...]
NTG Nordic Transport Group publishes interim report for Q1 2024
07/05/2024
Company announcement no. 5 – 24 7 May 2024 NTG Nordic Transport Group publishes interim report for Q1 2024 The interim report for Q1 2024 is enclosed. In connection with publication of the results for Q1 2024, a [...]

Pages